Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Operating Leases (2022 - 2025)

Historic Operating Leases for Rapid Micro Biosystems (RPID) over the last 4 years, with Q3 2025 value amounting to $4.0 million.

  • Rapid Micro Biosystems' Operating Leases fell 2393.08% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 2393.08%. This contributed to the annual value of $5.0 million for FY2024, which is 2027.68% down from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Operating Leases stood at $4.0 million, which was down 2393.08% from $4.3 million recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Operating Leases high stood at $7.7 million for Q2 2022, and its period low was $4.0 million during Q3 2025.
  • For the 4-year period, Rapid Micro Biosystems' Operating Leases averaged around $6.1 million, with its median value being $6.2 million (2023).
  • Per our database at Business Quant, Rapid Micro Biosystems' Operating Leases tumbled by 589.83% in 2023 and then crashed by 2393.08% in 2025.
  • Over the past 4 years, Rapid Micro Biosystems' Operating Leases (Quarter) stood at $7.2 million in 2022, then dropped by 13.72% to $6.2 million in 2023, then decreased by 20.28% to $5.0 million in 2024, then decreased by 19.22% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.3 million for Q2 2025, and $4.6 million during Q1 2025.